■ MATERIAL WEAKNESS WATCH
Nasdaq · CIK 0001196298

NEPH NEPHROS INC

B
80 / 100
Material weaknesses
1
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
20
Remediation credit
0

Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.

Disclosures, in the company's words

  • Material weakness10-Q · filed 2026-11-05 · Item 4source filing ↗
    “As previously disclosed in Part I, Item 4 of our Quarterly Report on Form 10-Q for the period ended June 30, 2025, management identified a material weakness in our internal control over financial reporting related to the recognition of revenue from contracts that included a combination of products sales and service-based deliverables and the application of ASC 606.”
  • Controls not effective10-Q · filed 2026-11-05 · Item 4source filing ↗
    “Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were not effective as of September 30, 2026, due to the existence of a material weakness in our internal control over financial reporting, as discussed below.”

Filings read

Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.